Zovirax site receives FDA Warning Letter

Share this article:
The Zovirax (acyclovir) ointment Web site, along with a consumer STD awareness deck card, misleadingly suggest to consumers that the GlaxoSmithKline product may prevent transmission of genital herpes infections, according to an FDA Warning Letter. The agency says that neither substantial evidence nor clinical experience have demonstrated this claim.
Share this article:
close

Next Article in News

Email Newsletters

More in News

AstraZenca beefs up respiratory portfolio

AstraZenca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.

Amgen Q2 sales rise, company to lay off up to 2,900

Amgen Q2 sales rise, company to lay off ...

The majority of the layoffs will be in the US.

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...